Literature DB >> 1684758

The transmissible amyloidoses: genetical control of spontaneous generation of infectious amyloid proteins by nucleation of configurational change in host precursors: kuru-CJD-GSS-scrapie-BSE.

D C Gajdusek1.   

Abstract

Kuru, Creutzfeld-Jakob disease, Gerstmann-Sträussler syndrome, scrapie, and bovine spongiform encephalopathy are caused by so-called unconventional viruses which are really replicating proteins which induce by auto nucleation and autopatterning a configurational change in the precursor protein to produce an infectious amyloid form. Crystallography and NMR may eventually determine how amyloid precursor protein is converted to this infectious form by configurational changes in all tertiary and quaternary structure of the normal precursor. Most sporadic cases of CJD arise by de novo spontaneous conversion of the normal precursor to the infectious form, a rare event occurring at the frequency of one per million persons per year (the annual incidence of CJD throughout the world). In the familial forms of CJD and GSS, where the occurrence is an autosomal dominant trait, each family has one of five different mutations causing a single amino acid change or one of five insertions of 5, 6, 7, 8 or 9 octapeptide repeats. Each mutation causes a million-fold increased probability of the spontaneous configurational change to an infectious polypeptide, and appears as an autosomal dominant trait. Thus, the behavior of the transmissible brain amyloidosis parallels completely that of the transthyretin amyloidoses causing familial amyloidotic polyneuropathy, in which there are 19 different point mutations, each one of which increases enormously the likelihood of configurational change of transthyretin prealbumin to amyloid.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1684758     DOI: 10.1007/bf00143141

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  54 in total

1.  Familial Creutzfeldt-Jakob disease in Chile is associated with the codon 200 mutation of the PRNP amyloid precursor gene on chromosome 20.

Authors:  P Brown; S Gálvez; L G Goldfarb; A Nieto; L Cartier; C J Gibbs; D C Gajdusek
Journal:  J Neurol Sci       Date:  1992-10       Impact factor: 3.181

Review 2.  The new biology of spongiform encephalopathy: infectious amyloidoses with a genetic twist.

Authors:  P Brown; L G Goldfarb; D C Gajdusek
Journal:  Lancet       Date:  1991-04-27       Impact factor: 79.321

3.  New mutation in scrapie amyloid precursor gene (at codon 178) in Finnish Creutzfeldt-Jakob kindred.

Authors:  L G Goldfarb; M Haltia; P Brown; A Nieto; J Kovanen; W R McCombie; S Trapp; D C Gajdusek
Journal:  Lancet       Date:  1991-02-16       Impact factor: 79.321

4.  Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker's syndrome.

Authors:  D Goldgaber; L G Goldfarb; P Brown; D M Asher; W T Brown; S Lin; J W Teener; S M Feinstone; R Rubenstein; R J Kascsak
Journal:  Exp Neurol       Date:  1989-11       Impact factor: 5.330

Review 5.  Transmissible and non-transmissible amyloidoses: autocatalytic post-translational conversion of host precursor proteins to beta-pleated sheet configurations.

Authors:  D C Gajdusek
Journal:  J Neuroimmunol       Date:  1988-12       Impact factor: 3.478

6.  Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease.

Authors:  M S Palmer; A J Dryden; J T Hughes; J Collinge
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

7.  Structure of the chromosomal gene for human serum prealbumin.

Authors:  H Sasaki; N Yoshioka; Y Takagi; Y Sakaki
Journal:  Gene       Date:  1985       Impact factor: 3.688

8.  Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A.

Authors:  C C Blake; M J Geisow; S J Oatley; B Rérat; C Rérat
Journal:  J Mol Biol       Date:  1978-05-25       Impact factor: 5.469

9.  Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering.

Authors:  C L Masters; J O Harris; D C Gajdusek; C J Gibbs; C Bernoulli; D M Asher
Journal:  Ann Neurol       Date:  1979-02       Impact factor: 10.422

10.  High incidence of Creutzfeldt-Jakob disease in North African immigrants to France.

Authors:  F Cathala; P Brown; P LeCanuet; D C Gajdusek
Journal:  Neurology       Date:  1985-06       Impact factor: 9.910

View more
  8 in total

Review 1.  Prions on the move.

Authors:  Charles Weissmann; Jiali Li; Sukhvir P Mahal; Shawn Browning
Journal:  EMBO Rep       Date:  2011-10-28       Impact factor: 8.807

2.  Cellular prion protein is present in mitochondria of healthy mice.

Authors:  Robert Faris; Roger A Moore; Anne Ward; Brent Race; David W Dorward; Jason R Hollister; Elizabeth R Fischer; Suzette A Priola
Journal:  Sci Rep       Date:  2017-02-02       Impact factor: 4.379

Review 3.  Implications of peptide assemblies in amyloid diseases.

Authors:  Pu Chun Ke; Marc-Antonie Sani; Feng Ding; Aleksandr Kakinen; Ibrahim Javed; Frances Separovic; Thomas P Davis; Raffaele Mezzenga
Journal:  Chem Soc Rev       Date:  2017-10-30       Impact factor: 54.564

Review 4.  Prions, beta-sheets and transmissible dementias: is there still something missing?

Authors:  P P Liberski
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 5.  Spontaneous generation of infectious nucleating amyloids in the transmissible and nontransmissible cerebral amyloidoses.

Authors:  D C Gajdusek
Journal:  Mol Neurobiol       Date:  1994-02       Impact factor: 5.590

6.  Safety Profile Investigations of Meyna spinosa (Roxb.) and Oroxylum indicum (Linn.) Extracts Collected from Northeast India.

Authors:  Shweta Singh; Pronobesh Chattopadhyay; Sahindra Kumar Borthakur; Rudragoud Policegoudra
Journal:  Pharmacogn Mag       Date:  2018-01-31       Impact factor: 1.085

7.  Modifications of transthyretin in amyloid fibrils: analysis of amyloid from homozygous and heterozygous individuals with the Met30 mutation.

Authors:  C Thylén; J Wahlqvist; E Haettner; O Sandgren; G Holmgren; E Lundgren
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

Review 8.  Review. Kuru and its contribution to medicine.

Authors:  D Carleton Gajdusek
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-11-27       Impact factor: 6.237

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.